scorecardresearch
Add as a preferred source on Google
Saturday, November 8, 2025
TopicCovid-19 vaccine

Topic: Covid-19 vaccine

Hyderabad’s CCMB to set up exclusive lab to develop RNA tech for use in Covid vaccines

Development comes amid talks the Centre for Cellular and Molecular Biology is holding with Moderna to manufacture the American biotech firm’s vaccine in India.

Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod

Kirill Dmitriev, CEO of Russian Direct Investment Fund that makes Sputnik V, also says majority of vaccine doses will be manufactured in India.

Why it takes 2 shots to make mRNA vaccines do the trick

This is what happens to the human body between the first and second dose of an mRNA vaccine.

EU’s U-turn on Covid vaccine exports to UK, and the ‘gutless QAnon party’

The best cartoons of the week, chosen by the editors at ThePrint.

CSIR in talks to bring Moderna’s Covid vaccine to India, says its chief Shekhar Mande

Mande says current talks are scientific, and once CSIR’s Hyderabad-based CCMB understands Moderna’s mRNA technology, it can produce the vaccine ‘within weeks’.

Indian vaccine makers excellent example for lower income countries, Gavi deputy CEO says

Anuradha Gupta, deputy CEO of Gavi, the global vaccine alliance, tells ThePrint India is crucial for the global Covid vaccine response.

Unlike rest of the world, India has plenty of Covid vaccines but few takers

As of 25 January 2021, only about 56% of people eligible to get the shot have stepped forward in a nation with the world’s second-worst Covid-19 outbreak.

Indians must have no confusion about how we reached impressive Covid herd immunity

India’s masses didn’t have the luxury to ‘work from home’ and follow social distancing, but they might have silently built India’s herd immunity.

Adverse events reported in just 0.08% of 15 lakh Covid vaccinations in first week

Most AEFIs reported were minor, such as fever or pain at the injection site. Only 11 people needed to be hospitalised, across six states and capital Delhi.

Why a ‘mucosal’ Covid vaccine has a better shot at ending the pandemic

Novel coronavirus is a pathogen of a ‘mucosal’ organ, different to ‘systemic’ organs. Current vaccines are systemic, and can only reduce disease severity.

On Camera

Trump’s unpredictability is not the absence of strategy—it works on everyone but China

The Italian term sprezzatura—a studied nonchalance that conceals intention—best captures the spirit of Trump’s foreign policy so far. The pattern is unpredictability, transactionalism, and disruption as diplomacy.

Asia’s ‘weakest’ link: Yunus on a tightrope as Bangladesh tries to fix banks without breaking economy

With 20.2 percent of its total loans in default by the end of last year, Bangladesh had the weakest banking system in Asia. Despite reforms, it will take time to recover.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.